Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 26, 2012, Pages 10468-10473

  Gotot, Janine ^a   Gottschalk, Catherine ^a   Leopold, Sonny ^a   Knolle, Percy A ^a   Yagita, Hideo ^b   Kurts, Christian ^a   Ludwig Portugall, Isis ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibodies; Autoimmunity; Inhibitory receptors; Peripheral tolerance

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL SURFACE PROTEIN; KIDNEY ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; HELPER CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIGANDS; MICE; PROGRAMMED CELL DEATH 1 RECEPTOR; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

MUS MUSCULUS;

EID: 84862997711     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201131109     Document Type: Article

References (45)

1. Frey O, et al. (2005) The role of regulatory T cells in antigen-induced arthritis: Aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7:R291-R301.
2. Reddy J, et al. (2004) Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 101:15434-15439. (Pubitemid 39441559)
3. Salomon B, et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440.
4. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2:1126-1132. (Pubitemid 33130146)
5. Seo SJ, et al. (2002) The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16:535-546.
6. Ludwig-Portugall I, Hamilton-Williams EE, Gotot J, Kurts C (2009) CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens. Eur J Immunol 39:225-233.
7. Ludwig-Portugall I, Hamilton-Williams EE, Gottschalk C, Kurts C (2008) Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J Immunol 181:4447-4451.
8. Fields ML, et al. (2005) CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. Journal Immunol 175(7):4255-4264. (Pubitemid 41361959)
9. Lim HW, Hillsamer P, Banham AH, Kim CH (2005) Cutting edge: Direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 175:4180-4183. (Pubitemid 41361949)
10. Iikuni N, Lourenço EV, Hahn BH, La Cava A (2009) Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J Immunol 183:1518-1522.
11. Janssens W, et al. (2003) CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol 171:4604-4612. (Pubitemid 37310576)
12. Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM (2006) Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107:3925-3932. (Pubitemid 43726798)
13. Chung Y, et al. (2011) Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 17:983-988.
14. Linterman MA, et al. (2011) Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 17:975-982.
15. Campbell DJ, Koch MA (2011) Treg cells: Patrolling a dangerous neighborhood. Nat Med 17:929-930.
16. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: How do they suppress immune responses? Int Immunol 21:1105-1111.
17. Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30:636-645.
18. Agata Y, et al. (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8:765-772. (Pubitemid 26148299)
19. Ishida Y, Agata Y, Shibahara K, Honjo T (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11:3887-3895.
20. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8:239-245. (Pubitemid 46745373)
21. Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704. (Pubitemid 351600389)
22. Blackburn SD, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10(1):29-37.
23. Mueller SN, et al. (2010) PD-L1 has distinct functions in hematopoietic and non-hematopoietic cells in regulating T cell responses during chronic infection in mice. J Clin Invest 120:2508-2515.
24. Diehl L, et al. (2008) Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 47:296-305. (Pubitemid 351171067)
25. Freeman GJ, et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027-1034.
26. Latchman Y, et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2:261-268. (Pubitemid 33706004)
27. Francisco LM, Sage PT, Sharpe AH (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236:219-242.
28. Greenwald RJ, Latchman YE, Sharpe AH (2002) Negative co-receptors on lymphocytes. Curr Opin Immunol 14:391-396. (Pubitemid 34327984)
29. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2003) CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found Symp, 252: 67-88; discussion 88-91, 106-114.
30. Good-Jacobson KL, et al. (2010) PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol 11:535-542.
31. Nishimura H, Minato N, Nakano T, Honjo T (1998) Immunological studies on PD-1 deficient mice: Implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10:1563-1572. (Pubitemid 28451451)
32. Heymann F, et al. (2009) Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 119:1286-1297.
33. Kurts C, Heymann F, Lukacs-Kornek V, Boor P, Floege J (2007) Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol 29:317-335. (Pubitemid 350077267)
34. Yamazaki T, et al. (2002) Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169:5538-5545. (Pubitemid 35291652)
35. Kao C, et al. (2011) Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat Immunol 12:663-671.
36. Yamazaki T, et al. (2005) Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J Immunol 175:1586-1592. (Pubitemid 41023060)
37. Chtanova T, et al. (2004) T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173(1):68-78. (Pubitemid 38797327)
38. Wong M, La Cava A, Singh RP, Hahn BH (2010) Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease. J Immunol 185:6563-6571.
39. Guay HM, Larkin, J, III, Picca CC, Panarey L, Caton AJ (2007) Spontaneous autoreactive memory B cell formation driven by a high frequency of autoreactive CD4+ T cells. J Immunol 178:4793-4802. (Pubitemid 46595261)
40. Prokunina L, et al. (2004) The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 50:327-328. (Pubitemid 38084318)
41. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98:13866-13871. (Pubitemid 33115990)
42. Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280-289.
43. Stagg J, et al. (2011) Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy. Proc Natl Acad Sci USA 108:7142-7147.
44. Radziewicz H, Hanson HL, Ahmed R, Grakoui A (2008) Unraveling the role of PD-1/PDL interactions in persistent hepatotropic infections: Potential for therapeutic application? Gastroenterology 134:2168-2171. (Pubitemid 351783277)
45. Velu V, et al. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458:206-210.